ARCHIVES

Conferess Ok $10.9 Bil. NIH Bidget, OAM to Get $3.5 Million

This article is from The Cancer Letter archive.

Vol. 19 No. 40 | October 15, 1993

Download PDF Visit The Full Archive

Related Articles

IARC Publishes Fourth Edition of European Code Against Cancer

October 17, 2014

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

AACR Selects Eight Finalists To Compete For $15 Million Grants Funded By Telethon.

December 5, 2008

Diet/Cancer Product ad Seminar Consensus: It’s Okay When Limited To Categories Of Food

November 7, 1986

Consortium Aims To Make Mice Whose Cancers Act Human.

January 7, 2000

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

July 28, 2000